BIORA THERAPEUTICS INC (PROG) Forecast, Price Target & Analyst Ratings

NASDAQ:PROG • US74319F1075

Current stock price

0.8845
-0.03 (-3.47%)
At close:
0.9
+0.02 (+1.75%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIORA THERAPEUTICS INC (PROG).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 361.28% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 10, 2022
Period
Q1 / 2022
EPS Estimate
-$0.13
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 361.28%
From current price of $0.88 to mean target of $4.08, Based on 7 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for PROG. The average price target is 4.08 null. This implies a price increase of 361.28% is expected in the next year compared to the current price of 0.8845.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PROG Current Analyst RatingPROG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

PROG Historical Analyst RatingsPROG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
PROG was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PROG.
In the previous month the buy percentage consensus was at a similar level.
PROG was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-10-14HC Wainwright & Co.Initiate Buy
2021-06-03Raymond JamesDowngrade Outperform -> Market Perform
2021-06-03BairdDowngrade Outperform -> Neutral
2021-05-17Wells FargoMaintains Underweight
2021-05-14Raymond JamesMaintains Outperform
2021-02-08Wells FargoDowngrade Overweight -> Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 10, 2022
Period
Q1 / 2022
EPS Estimate
-$0.13
Revenue Estimate
Revenue Q2Q
-100.00%
EPS Q2Q
77.23%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

PROG is expected to report earnings on 8/10/2022. The consensus EPS estimate for the next earnings is -0.13 null and the consensus revenue estimate is 0 null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
PROG revenue by date.PROG revenue by date.
144M
12.50%		74.3M
-48.40%		1.247M
-98.32%
-100.00%
EBITDA
YoY % growth
PROG ebitda by date.PROG ebitda by date.
-133.75M
-23.69%		-190.14M
-42.16%		-116.4M
38.78%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
PROG ebit by date.PROG ebit by date.
-140.1M
-22.68%		-195.2M
-39.33%		-117.837M
39.63%		N/AN/AN/AN/AN/A
Operating Margin
PROG operating margin by date.PROG operating margin by date.
-97.29%-262.72%-9,449.64%N/AN/AN/AN/AN/A
EPS
YoY % growth
PROG eps by date.PROG eps by date.
N/AN/A-2.23
64.98%		-0.50
77.59%		-0.50-0.52
-4.08%		-0.50
3.96%		-0.49
2.04%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.13
77.23%		-0.12
81.17%		-0.11
76.72%		-0.13
76.32%		-0.09
28.00%		-0.07
41.67%		-0.05
52.38%		-0.05
61.54%
Revenue
Q2Q % growth
-100.00%
-100.00%
-100.00%
-100.00%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PROG Yearly Revenue VS EstimatesPROG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 50M 100M
PROG Yearly EPS VS EstimatesPROG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
20.89%
EPS Next 5 Year
12.23%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BIORA THERAPEUTICS INC / PROG Forecast FAQ

What is the average price target for BIORA THERAPEUTICS INC (PROG) stock?

7 analysts have analysed PROG and the average price target is 4.08 null. This implies a price increase of 361.28% is expected in the next year compared to the current price of 0.8845.

When does BIORA THERAPEUTICS INC (PROG) report earnings?

BIORA THERAPEUTICS INC (PROG) will report earnings on 2022-08-10.

What are the consensus estimates for BIORA THERAPEUTICS INC (PROG) next earnings?

The consensus EPS estimate for the next earnings of BIORA THERAPEUTICS INC (PROG) is -0.13 null and the consensus revenue estimate is 0 null.

Can you provide the consensus rating for BIORA THERAPEUTICS INC stock?

The consensus rating for BIORA THERAPEUTICS INC (PROG) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.